These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15886638)

  • 21. A patient with chronic labial oedema and nodular palatal lesions.
    Gonzalez-Olivares M; Moreno-Torres A; Navarro-Vidal B; Cordoba S; Garrido-Rios AA; Ruiz-Giardin JM; Borbujo J
    Clin Exp Dermatol; 2018 Jun; 43(4):481-484. PubMed ID: 29344972
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mucocutaneous lesions produced by Leishmania Braziliensis].
    Lasala Carreras A
    Acta Odontol Venez; 1974 Apr; 12(1):3-21. PubMed ID: 4535200
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of tegumental leishmaniasis].
    Azulay RD
    Hospital (Rio J); 1966 Nov; 70(5):1231-41. PubMed ID: 5301941
    [No Abstract]   [Full Text] [Related]  

  • 24. Progressive Perforation of the Nasal Septum Due to
    Harrison N; Walochnik J; Ramsebner R; Veletzky L; Lagler H; Ramharter M
    Am J Trop Med Hyg; 2017 Mar; 96(3):653-655. PubMed ID: 28138053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Case report on gummatous skin leishmaniasis].
    Pilgrim M; Weber G
    Hautarzt; 1972 Feb; 23(2):83-5. PubMed ID: 5012286
    [No Abstract]   [Full Text] [Related]  

  • 26. Mucocutaneous leishmaniasis associated with HIV infection treated successfully with liposomal amphotericin B (AmBisome).
    Amato VS; Nicodemo AC; Amato JG; Boulos M; Neto VA
    J Antimicrob Chemother; 2000 Aug; 46(2):341-2. PubMed ID: 10933674
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of mucocutaneous (American) leishmaniasis with amphotericin B: report of 70 cases.
    Sampaio SA; Castro RM; Dillon NL; Martins JE
    Int J Dermatol; 1971; 10(3):179-81. PubMed ID: 5116171
    [No Abstract]   [Full Text] [Related]  

  • 28. American tegumentary leishmaniasis: diagnostic and treatment challenges in a clinical case.
    Oyama J; Ferreira FBP; Conter CC; Lera-Nonose DSSL; Ramos-Milaré ÁCFH; Venazzi EAS; Silveira TGV; Lonardoni MVC
    Rev Inst Med Trop Sao Paulo; 2018; 60():e3. PubMed ID: 29451600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mucocutaneous leishmaniasis and of the oral cavity].
    Gombos F; Laino G; Femiano F
    Arch Stomatol (Napoli); 1984; 25(4):349-57. PubMed ID: 6599651
    [No Abstract]   [Full Text] [Related]  

  • 30. Can we use a lower dose of liposomal amphotericin B for the treatment of mucosal American leishmaniasis?
    Amato VS; Tuon FF; Camargo RA; Souza RM; Santos CR; Nicodemo AC
    Am J Trop Med Hyg; 2011 Nov; 85(5):818-9. PubMed ID: 22049033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mucocutaneous leishmaniasis in otorhinolaryngology].
    Patuano E; Carrat X; Drouet Y; Barnabé D; Vincey P; Berthelot B
    Ann Otolaryngol Chir Cervicofac; 1993; 110(7):415-9. PubMed ID: 8085723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary oral leishmaniasis mimicking oral cancer: a case report.
    Celentano A; Ruoppo E; Mansueto G; Mignogna MD
    Br J Oral Maxillofac Surg; 2015 Apr; 53(4):396-8. PubMed ID: 25701438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experience with endemic dermatological diseases in the Peruvian wilderness: mucocutaneous leishmaniasis and Brazilian foliaceous pemphigus].
    Heimgartner E; De Heimagartner V
    Med Cutan Ibero Lat Am; 1976; 4(1):1-6. PubMed ID: 135891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis and differential diagnosis of cutaneous leishmaniasis. Report on seven cases observed in Zurich].
    Schwarz KJ
    Schweiz Med Wochenschr; 1970 Nov; 100(48):2073-8. PubMed ID: 5524728
    [No Abstract]   [Full Text] [Related]  

  • 35. [American mucocutaneous leishmaniasis].
    Kalamkarian AA; Samsonov VA; Fedorov SM; Sukolin GI; Kellina OI
    Sov Med; 1986; (5):105-7. PubMed ID: 3726614
    [No Abstract]   [Full Text] [Related]  

  • 36. Reprint of: Man with severe mucocutaneous leishmaniasis.
    Cárdenas GAP; Travezaño JER; Chavez MSC
    Dis Mon; 2022 Sep; 68(9):101425. PubMed ID: 35644649
    [No Abstract]   [Full Text] [Related]  

  • 37. A randomized trial of amphotericin B alone or in combination with itraconazole in the treatment of mucocutaneous leishmaniasis.
    Rodriguez LV; Dedet JP; Paredes V; Mendoza C; Cardenas F
    Mem Inst Oswaldo Cruz; 1995; 90(4):525-8. PubMed ID: 8551959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucocutaneous leishmaniasis complicating systemic lupus erythematosus and responding to high dose amphotericin B.
    Matos AL; Figueiredo C; Alves F; Pereira N; Gonçalo M
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e756-e758. PubMed ID: 34057771
    [No Abstract]   [Full Text] [Related]  

  • 39. [A patient with long-term, unrecognized leishmaniasis].
    Rabelink NM; de Steenwinkel JE; van Biezen P; van Daele PL; Gyssens IC
    Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2715-9. PubMed ID: 17194010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucocutaneous leishmaniasis with marked facial disfigurement.
    Ekiz O; Kahraman ŞŞ; Şen BB; Serarslan G; Rifaioğlu EN; Culha G; Özgür T
    Indian J Dermatol Venereol Leprol; 2017; 83(1):91-93. PubMed ID: 27643545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.